Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11919903 Polymorphs

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Thomas Nicola0

Dirk Kemmer0

Martin Renz0

Peter Sieger0

Peter Kohlbauer0

Date of Patent

March 5, 2024

0

Patent Application Number

173634410

Date Filed

June 30, 2021

0

Patent Citations

US Patent 9212183 Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine

0

US Patent 9493462 Polymorphs

0

US Patent 9815837 Polymorphs

0

US Patent 10023574 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

0

US Patent 10034877 Treatment for diabetes in patients inappropriate for metformin therapy

0

US Patent 10092571 Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin

0

US Patent 10155000 Medical use of pharmaceutical combination or composition

0

US Patent 8399414 Analgesics

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

Patent abstract

The invention relates to polymorphous crystal modifications of a DPP-IV inhibitor, the preparation thereof and the use thereof for preparing a medicament.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11919903 Polymorphs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool